| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,270,000 |
| Market
Cap: |
2.68(B) |
| Last
Volume: |
676,829 |
Avg
Vol: |
540,793 |
| 52
Week Range: |
$23.14 - $45.97 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 14.3 |
| Insider 6 Months : 14.3 |
| Insider 3/6 Months : 28.8 |
|
| Guru Rank Number : 364 |
| Guru Rank Value : 3.4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Integra LifeSciences Holdings, a provider of medical devices, is engaged in the development, manufacturing, and marketing of surgical implants and medical instruments. Its products are used primarily in neurosurgery, reconstruction and general surgery. Co.'s segments are: Codman Specialty Surgical, which provides global, neurosurgery technologies, brands and instrumentation; and Orthopedics and Tissue Technologies, which address the needs of plastic, reconstructive and general surgeons focused on the treatment of acute wounds, such as burns, chronic wounds, including diabetic foot ulcers, and surgical tissue repair, such as hernia, tendon, peripheral nerve repair and protection.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
88,991 |
88,991 |
88,991 |
99,423 |
| Total Buy Value |
$2,495,795 |
$2,495,795 |
$2,495,795 |
$2,895,816 |
| Total People Bought |
2 |
2 |
2 |
4 |
| Total Buy Transactions |
2 |
2 |
2 |
4 |
| Total Shares Sold |
0 |
8,348 |
9,525 |
27,482 |
| Total Sell Value |
$0 |
$305,492 |
$357,821 |
$1,361,197 |
| Total People Sold |
0 |
1 |
2 |
5 |
| Total Sell Transactions |
0 |
1 |
2 |
10 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mooradian John |
Corp VP, Global Ops & Supp Chn |
• – – |
2017-03-23 |
4 |
D |
$42.35 |
$23,208 |
D/D |
(548) |
16,172 |
|
- |
|
| Davis Robert T. Jr. |
CVP,PRES-ORTHO & TISSUE TECH |
• – – |
2017-03-23 |
4 |
D |
$42.35 |
$45,823 |
D/D |
(1,082) |
35,159 |
|
- |
|
| Gorelick Richard D. |
Corp VP, Gen Counsel & Sec |
• – – |
2017-03-23 |
4 |
D |
$42.35 |
$26,088 |
D/D |
(616) |
24,360 |
|
- |
|
| Burhop Kenneth |
CORPVP,CHIEFSCIENTIFIC OFFICER |
• – – |
2017-03-23 |
4 |
D |
$42.35 |
$23,504 |
D/D |
(555) |
7,370 |
|
- |
|
| Coleman Glenn |
CVP, CHIEF FINANCIAL OFFICER |
• – – |
2017-03-23 |
4 |
D |
$42.35 |
$58,358 |
D/D |
(1,378) |
38,931 |
|
- |
|
| Arduini Peter J |
President & CEO |
• • – |
2017-03-23 |
4 |
D |
$42.35 |
$493,843 |
D/D |
(11,661) |
104,517 |
|
- |
|
| Arduini Peter J |
President & CEO |
• • – |
2017-03-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
353 |
104,870 |
|
- |
|
| Vinhais Joseph |
Corp VP,Global Qlty Assurance |
• – – |
2017-03-15 |
4 |
S |
$43.48 |
$72,603 |
D/D |
(1,670) |
10,202 |
|
- |
|
| Coleman Glenn |
CVP, CHIEF FINANCIAL OFFICER |
• – – |
2017-03-15 |
4 |
S |
$43.19 |
$192,733 |
D/D |
(4,462) |
40,309 |
|
- |
|
| Ogrady Judith |
CorpVP,Global Reg.Affairs |
• – – |
2017-03-14 |
4 |
D |
$43.03 |
$14,071 |
D/D |
(327) |
21,116 |
|
- |
|
| Reuvers Daniel L. |
CVP,PRES-SPC SURGICAL SOLUTION |
• – – |
2017-03-14 |
4 |
D |
$43.03 |
$24,054 |
D/D |
(559) |
23,776 |
|
- |
|
| Coleman Glenn |
CVP, CHIEF FINANCIAL OFFICER |
• – – |
2017-03-14 |
4 |
D |
$43.03 |
$97,764 |
D/D |
(2,272) |
44,771 |
|
- |
|
| Murphy Raymond G. |
Director |
– • – |
2017-03-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
28,761 |
28,761 |
|
- |
|
| Murphy Raymond G. |
Director |
– • – |
2017-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
28,761 |
32,133 |
|
- |
|
| Ogrady Judith |
CorpVP,Global Reg.Affairs |
• – – |
2017-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
573 |
21,443 |
|
- |
|
| Reuvers Daniel L. |
CVP,PRES-SPC SURGICAL SOLUTION |
• – – |
2017-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,718 |
24,335 |
|
- |
|
| Coleman Glenn |
CVP, CHIEF FINANCIAL OFFICER |
• – – |
2017-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,266 |
47,043 |
|
- |
|
| Arduini Peter J |
President & CEO |
• • – |
2017-02-27 |
4 |
AS |
$42.28 |
$2,030,230 |
D/D |
(48,018) |
131,555 |
|
- |
|
| Arduini Peter J |
President & CEO |
• • – |
2017-02-27 |
4 |
OE |
$13.89 |
$555,600 |
D/D |
40,000 |
171,555 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2017-02-24 |
4 |
D |
$42.33 |
$2,751 |
D/D |
(65) |
32,951 |
|
- |
|
| Coleman Glenn |
CVP, CHIEF FINANCIAL OFFICER |
• – – |
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
17,251 |
41,777 |
|
- |
|
| Ogrady Judith |
CorpVP,Global Reg.Affairs |
• – – |
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,864 |
20,870 |
|
- |
|
| Arduini Peter J |
President & CEO |
• • – |
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,387 |
139,573 |
|
- |
|
| Reuvers Daniel L. |
CVP,PRES-SPC SURGICAL SOLUTION |
• – – |
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,959 |
22,617 |
|
- |
|
| Davis Robert T. Jr. |
CVP,PRES-ORTHO & TISSUE TECH |
• – – |
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,601 |
34,937 |
|
- |
|
1409 Records found
|
|
Page 22 of 57 |
|
|
0.15 (0.47%) 
